학술논문
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients
Document Type
Article
Author
Source
In Clinical Genitourinary Cancer February 2022 20(1):53-59
Subject
Language
ISSN
1558-7673